N-(PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS Russian patent published in 2024 - IPC C07D471/00 A61K31/444 A61K31/4545 A61K31/496 

Abstract RU 2831159 C2

FIELD: chemistry.

SUBSTANCE: invention relates to compounds of formula II and formula VII, and pharmaceutically acceptable salts thereof. In formula II: Y is -O-; R2 is -NO2; R4a is selected from a group consisting of unsubstituted C1-6 alkyl and (heterocyclo)alkyl. In formula VII: Y is selected from a group consisting of -CH2- and -O-; X1, X2, and X3 each independently represents -CR8=; R2 is -NO2; R4a is selected from the group consisting of unsubstituted C1-6 alkyl and (heterocyclo)alkyl; and R8 is hydrogen. (Heterocyclo)alkyl is C1-4 alkyl substituted with one heterocyclyl group, where the heterocyclyl group is 6-member cyclic group containing one ring and one or two oxygen atoms.

EFFECT: disclosed compounds inhibit Bcl-2 proteins and are used in treating a disease, disorder or condition susceptible to Bcl-2 protein inhibition, such as cancer.

4 cl, 4 dwg, 7 tbl, 20 ex

Similar patents RU2831159C2

Title Year Author Number
N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS 2017
  • Wang, Shaomeng
  • Chen, Jianyong
RU2722560C1
N- (PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS 2017
  • Wang, Shaomeng
  • Chen, Jianyong
RU2744358C2
BENZAMIDE COMPOUNDS 2019
  • Pinchman, Dzhozef Robert
  • Khuan, Piter Tsinkhua
  • Banker, Kevin Duejn
  • Sit, Rakesh Kumar
  • Samatar, Akhmed Abdi
RU2801647C2
APOPTOSIS-INDUCING AGENTS FOR TREATING MALIGNANT TUMOURS AND IMMUNE AND AUTOIMMUNE DISEASES 2010
  • Branko Milan
  • Din Khun
  • Douehrti Dzhordzh
  • Ehlmor Stiven
  • Khasvol'D Liza
  • Kheksamer Laura
  • Kanzer Aaron R.
  • Sun Sjaokhun
  • Sauehrs Ehndrju Dzh.
  • Sallivan Dzherard
  • Tao Chzhi-Fu
  • Van Gari T.
  • Van Leh
  • Van Silu
  • Uehndt Majkl
  • Mantej Robert
  • Khansen Todd M.
RU2573832C2
APOPTOSIS INDUCING AGENTS FOR TREATING MALIGNANT NEW GROWTH, AND IMMUNE AND AUTOIMMUNE DISEASES 2010
  • Branko Milan
  • Din Khun
  • Douehrti Dzhordzh
  • Ehlmor Stiven
  • Khasvol'D Liza
  • Kheksamer Laura
  • Kanzer Aaron R.
  • Sun Sjaokhun
  • Sauehrs Ehndrju Dzh.
  • Sallivan Dzherard
  • Tao Chzhi-Fu
  • Van Gari T.
  • Van Leh
  • Van Silu
  • Uehndt Majkl
  • Mantej Robert
  • Khansen Todd M.
RU2535347C2
APOPTOSIS-INDUCING MEANS FOR TREATMENT OF MALIGNANT TUMOUR AND IMMUNE AND AUTOIMMUNE DISEASES 2015
  • Branko, Milan
  • Din, Khun
  • Douerti, Dzhordzh
  • Elmor, Stiven
  • Khasvold, Liza
  • Kheksamer, Laura
  • Kanzer, Aaron R.
  • Sun, Syaokhun
  • Sauers, Endryu Dzh.
  • Sallivan, Dzherard
  • Tao, Chzhi-Fu
  • Van, Gari T.
  • Van, Le
  • Van, Silu
  • Uendt, Majkl
  • Mantej, Robert
  • Khansen, Todd M.
RU2628885C2
APOPTOSIS-INDUCING AGENTS FOR TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 2014
  • Tao Chzhi-Fu
  • Van Silu
  • Uendt Majkl D.
  • Sauers Endryu Dzh.
  • Dzhadd Endryu S.
  • Kanzer Aaron
  • Sallivan Dzherard
RU2662812C2
APOPTOSIS-INDUCING MEDICATIONS FOR TREATING CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 2010
  • Branko Milan
  • Din Khun
  • Douehrti Dzhordzh
  • Ehlmor Stiven
  • Khasvol'D Liza
  • Kheksamer Laura
  • Kanzer Aaron R.
  • Sun Sjaokhun
  • Sauehrs Ehndrju Dzh.
  • Sallivan Dzherard
  • Tao Chzhi-Fu
  • Vang Gari T.
  • Van Leh
  • Van Silu
  • Uehndt Majkl
  • Mantej Robert
  • Khansen Todd M.
RU2554346C2
SOLID DISPERSIONS CONTAINING AGENTS CAUSING APOPTOSIS 2011
  • Ketron Nataniel D.
  • Lindli Devid Dzh.
  • Miller Dzhonatan
  • Shmitt Erik A.
  • Tun Pin
RU2598345C2
SOLID DISPERSIONS PRODUCED BY MELT EXTRUSION AND CONTAINING APOPTOSIS-INDUCING AGENT 2011
  • Resh Ester
  • Khelig Peter
  • Lindli Devid Dzh.
  • Sanzgiri Jeshvant D.
  • Tun Pin
RU2577859C2

RU 2 831 159 C2

Authors

Wang, Shaomeng

Chen, Jianyong

Dates

2024-12-02Published

2020-10-23Filed